CONCLUSION
In summary, CD15+LOX-1+ PMN-MDSC
proportion increases in PB of NSCLC patients, and combined detection of
PMN-MDSCs and traditional tumor markers can promote the diagnostic
sensitivity and specificity for NSCLC. Moreover,
CD15+LOX-1+ PMN-MDSCs are associated
with NSCLC prognosis and recurrence after surgery.